Nascobal 2021 U.S. PROMOTIONAL AUDIT REPORT

Published July 2022 • 28 Pages

The 5 Key Questions Addressed by this Report:

• How many physicians were reached by Nascobal through reportable promotional activity in 2021 to drive use within the Vitamin B12 Deficiency market?
• What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend on each type of activity?
• How does Endo’s depth of coverage vary within key specialties (e.g., Nursing, Internal Medicine, Family Medicine, General Surgery, Physician Assistant, Endocrinology, and Gastroenterology) and how does this compare to the overall set of rep-accessible physicians?
• How often are physicians receiving paid meals for Nascobal throughout the year (e.g., monthly, quarterly, annually)?
• Who were the most frequent meal recipients and top paid speakers for Nascobal in 2021?

Data Sources and Methodology:

• MDDetails leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, over 5 years of longitudinal data is available – covering payments to more than 1,000,000 U.S. healthcare professionals.
• Over 3,210 paid interactions across 1,810 physicians made on behalf of Nascobal were carefully examined to support our analysis.